Peter Cameron

Bio Tissue (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index1.2kcitations40works27.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(23), RNA and protein synthesis mechanisms(7), Advanced biosensing and bioanalysis techniques(5), Animal Virus Infections Studies(4), Mosquito-borne diseases and control(3)

Publications39 total

AppSelectBench: Application-Level Tool Selection Benchmark
arXiv (Cornell University)·2025Open Access
Design of highly functional genome editors by modelling CRISPR–Cas sequences
Nature·2025· 45 citedOpen Access
Engineering of CRISPR-Cas PAM recognition using deep learning of vast evolutionary data
2025· 4 citedOpen Access
Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences
2024· 82 citedOpen Access
Highly Specific Cas9 and Cas12a Engineering of Human T Cells for Generation of Novel Allogeneic Cell Therapies
Transplantation and Cellular Therapy·2024· 2 cited
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas
The CRISPR Journal·2024· 29 citedOpen Access
Author Correction: Mapping the genomic landscape of CRISPR–Cas9 cleavage
Nature Methods·2023· 1 citedOpen Access
SITE-Seq: A Genome-wide Method to Measure Cas9 Cleavage
2023· 2 citedOpen Access
Structural basis for Cas9 off-target activity
Cell·2022· 184 citedOpen Access
Structural basis for Cas9 off-target activity
2021· 4 citedOpen Access
Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells
Molecular Cell·2021· 62 citedOpen Access
Target-bound SpCas9 complex with TRAC full RNA guide
2021
Target-bound SpCas9 complex with AAVS1 all-RNA guide
2021
Target-bound SpCas9 complex with TRAC chimeric RNA-DNA guide
2021
Harnessing type I CRISPR–Cas systems for genome engineering in human cells
Nature Biotechnology·2019· 121 cited
NmeCas9 is an intrinsically high-fidelity genome-editing platform
Genome biology·2018· 132 citedOpen Access
Additional file 9: of NmeCas9 is an intrinsically high-fidelity genome-editing platform
Figshare·2018Open Access
Additional file 2: of NmeCas9 is an intrinsically high-fidelity genome-editing platform
Figshare·2018Open Access
Additional file 4: of NmeCas9 is an intrinsically high-fidelity genome-editing platform
Figshare·2018Open Access
Additional file 3: of NmeCas9 is an intrinsically high-fidelity genome-editing platform
Figshare·2018Open Access
page 1 of 2Next →

Frequent Co-authors

Paul D. Donohoue(20), Chris Fuller(18), Alexander Settle(14), Nadia Amrani(10), Pengpeng Liu(10), Alireza Edraki(10), Aamir Mir(10), Raed Ibraheim(10), Kanae Sasaki(10), Tong Wu(10), Kyle McGovern(10), Thomas G. Fazzio(10), Lihua Julie Zhu(10), Scot A. Wolfe(10), Erik J. Sontheimer(10), Alexandra Lied(9), P. K. Aw Pauline(9), Teoh Garrett(9), Duong Thi Hue Kien(9), Minh Nguyen Nguyet(9)